Literature DB >> 28895405

Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network.

C J Zhang, H J Du.   

Abstract

The safety of miRNAs has been proven and the prophylactic use of miRNA-based approaches may be foreseen for patients with hepatocellular carcinoma (HCC). However, the underlying regulatory mechanism of miRNAs in HCC has not been fully clarified. Using bioinformatic analyses, we compared data of miRNA and mRNA expression profiling of HCC from Gene Expression Omnibus (GEO) database, respectively. Differentially expressed miRNAs and differentially expressed genes (DEGs) were identified. Based on the miRTarBase predictions, the miRNA-dependent regulatory network was constructed. In total, comparative analysis of five mRNA datasets and two miRNA datasets led to 1449 DEGs and 17 differentially expressed miRNAs, respectively. Based on the predictions, a global miRNA-mRNA regulatory network was then constructed, which encompassed 451 miRNA target gene pairs whose expressions were inversely correlated. Three miRNAs (miR-641, miR-507 and miR-501-5p) were the most connected miRNAs that regulated a large number of genes, among which miR-641 and miR-507 were novel miRNAs altered in HCC. We suggested that miR-501-5p will represent a powerful therapeutic target for HCC. Moreover, four up-regulated miRNAs (miR-769-3p, miR-941, miR-362-3p and miR-16-1) and one down-regulated miRNA (miR-581) may be involved in HCC. Additionally, two targets of MAPK8 and SRPK2 were also detected in this study, whose roles in HCC will be notable. In conclusion, we developed an integrative approach to construct an interactive global network of miRNA-mRNA, which can contribute to refine miRNA target predictions for developing new therapeutic approaches.

Entities:  

Keywords:  Hepatocellular carcinoma; miRNAs; regulatory network integrated analysis.

Mesh:

Substances:

Year:  2017        PMID: 28895405     DOI: 10.4149/neo_2017_602

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  5 in total

1.  SCAMP3 is regulated by miR-128-3p and promotes the metastasis of hepatocellular carcinoma cells through EGFR-MAPK p38 signaling pathway.

Authors:  Le Kang; Ze-Hua Zhang; Ying Zhao
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

2.  MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.

Authors:  Dan Wang; Hongyan Wang; Yichun Li; Qian Li
Journal:  Biosci Rep       Date:  2018-06-21       Impact factor: 3.840

3.  MicroRNA-769-3p inhibits tumor progression in glioma by suppressing ZEB2 and inhibiting the Wnt/β-catenin signaling pathway.

Authors:  Kai Wang; Shasha Yang; Yishen Gao; Caihong Zhang; Qiangbo Sui
Journal:  Oncol Lett       Date:  2019-11-21       Impact factor: 2.967

4.  Circ_ASPH promotes cholangiocarcinoma growth and metastasis through the miR-581/ATP-binding cassette transporter G1 signaling pathway.

Authors:  Yi Xu; Pengcheng Kang; Kaiming Leng; Yue Yao; Guanqun Liao; Yi Han; Guangjun Shi; Xiangyu Zhong; Yunfu Cui
Journal:  Cancer Commun (Lond)       Date:  2020-07-31

5.  MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation.

Authors:  Sunil Kumar Surapaneni; Zahid Rafiq Bhat; Kulbhushan Tikoo
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.